Evaluation of incentives for R&D in the pharmaceutical industry with applications for neglected diseases
This thesis is concerned with the development of incentives for pharmaceutical R&D, specifically for neglected diseases. The following approaches are adopted. The short-term effects of the recent cost-containment reforms on seven financial indicators related to firms‘ R&D in Denmark, Germany...
| Main Author: | |
|---|---|
| Published: |
Queen Mary, University of London
2011
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.535785 |